VRNA Verona Pharma plc

6.25
-0.03  -1%
Previous Close 6.28
Open 6.24
Price To Book 0.98
Market Cap 82286431
Shares 13,165,829
Volume 6,071
Short Ratio
Av. Daily Volume 12,926

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2a data released March 2, 2018.
RPL554
Cystic fibrosis
Phase 2 trial did not meet primary endpoint - January 14, 2019.
RPL554
COPD
Phase 2 initiation announced December 17, 2018 with single dose part data due 1H 2019.
RPL554 DPI formulation
Maintenance treatment of COPD